A new study has led to Health and Human Services Secretary Robert F. Kennedy, Jr. to order a “complete review” of the ...

“The best way to prevent cavities in children is by avoiding excessive sugar intake and good dental hygiene, not by altering a child’s microbiome,” FDA Commissioner Dr. Marty Makary, said in the FDA ...

Clarity Pharmaceuticals (ASX: CU6) ("Clarity" or "Company"), a clinical-stage radiopharmaceutical company with a mission to develop next-generation products that improve treatment outcomes for ...

Clarity Pharmaceuticals (ASX: CU6) ("Clarity" or "Company"), a clinical-stage radiopharmaceutical company with a mission to ...

In the wake of mass restructuring efforts across the Department of Health and Human Services (HHS), the FDA has missed yet another approval decision target date. GSK had expected to secure an FDA ...

In April, the FDA cleared Verastem Oncology’s Investigational New Drug application of VS-7375, an oral KRAS G12D (ON/OFF) inhibitor for clinical evaluation. The company expects to initiate a ...

Fired workers from the Division of Drug Information, which conducts safety monitoring, say the DDI team lost between 75% and 90% of its roughly 50-person staff in the FDA’s April 1 reduction in ...

You can reach Lizzy on Signal at lizzylaw.53. WASHINGTON — In his first address to FDA staff on Wednesday, Vinay Prasad emphasized his commitment to evidence, his admiration for agency employees ...

Mifepristone is the first drug in the medication abortion regimen, which comprised nearly two-thirds of all abortions in 2023; conservatives want the FDA to end telemedicine prescriptions of the ...

Prasad replaces Dr. Peter Marks, who served as the director of the Center for Biologics Evaluation and Research at the FDA and played a key role in launching Operation Warp Speed — the Trump ...

FDA Commissioner Marty Makary named Vinay Prasad, a hematologist oncologist and critic of the Covid-19 vaccine for children, as the next director of the Center for Biologics and Research.

Recent reorganizations and "reductions in force" at the FDA have damaged the very backbone of our public health system. Gutted by Administration-initiated layoffs and seemingly ideologically-motivated ...